CJC-1295 (no DAC)
29-residue GHRH analog without the DAC linker (modified GRF 1-29); short-acting in GH-axis research.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 5 MG
-
-
CJC-1295 (no DAC) / Ipamorelin
GHRH analog (CJC-1295 no DAC) and ghrelin-receptor agonist (Ipamorelin) combined in one vial for GH-axis research.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 5 MG + 5 MG
-
CJC-1295 (with DAC)
GHRH analog with a drug affinity complex (DAC) that extends its circulating half-life in GH-axis studies.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 10 MG
-
GHRP-2
Synthetic hexapeptide ghrelin-receptor agonist (pralmorelin); GH secretagogue research.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 10 MG
-
GHRP-6
First-generation hexapeptide GH secretagogue, described in 1984; ghrelin-receptor research.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 5 MG
-
Ipamorelin
Pentapeptide ghrelin-receptor agonist, described in 1998 as a selective GH secretagogue.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 5 MG
-
Sermorelin
GHRH(1-29) analog; the reference compound in growth hormone-releasing hormone research.
- FORMAT
- LYOPHILIZED POWDER
- SPEC
- 5 MG
